Overcoming High Upfront Costs Through Innovative Financing Models
The pricing structure of modern, life-saving genetic treatments is one of the most widely discussed topics in the modern medical economics landscape. In the global Spinal Muscular Atrophy Market, single-dose curative therapies carry substantial upfront costs, which can initially overwhelm traditional fee-for-service insurance structures and public health budgets. To address this financial...
0 Comments 0 Shares 7 Views 0 Reviews